MBRX icon

Moleculin Biotech
MBRX

Overview Fund Activity

21 hedge funds and large institutions have $2.91M invested in Moleculin Biotech in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
-5
Holders Change %
-19.23%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
2
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$770K
2
TSS
2
Two Sigma Securities
New York
$55K
3
RJFSA
3
Raymond James Financial Services Advisors
Florida
$44K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.62M
5
Victory Capital Management
5
Victory Capital Management
Texas
$10K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$0
2
Millennium Management
2
Millennium Management
New York
$0
3
Bank of New York Mellon
3
Bank of New York Mellon
New York
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$0
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Commonwealth Equity Services
26
Commonwealth Equity Services
Massachusetts
– -$10K -133 Closed
CTB
27
Country Trust Bank
Illinois
– -$2K -28 Closed
Deutsche Bank
28
Deutsche Bank
Germany
– -$1K -12 Closed
1
2